The 9th Annual European Antibody Congress is the region’s largest event dedicated to scientific, technology and business development: an exhibition, a strategic keynote conference and real life case studies.
You should attend to see the latest clinical data from a range of players working on next generation antibodies, to network with the leaders, influencers and key R&D scientists, to evaluate the latest analytical technologies for use in antibody development, to learn how to overcome challenges in manufacturing, to hear the regulators thoughts on how biosimilar mAb approval will affect the antibody space.